Company profile: Renalytix
1.1 - Company Overview
Company description
- Provider of AI-enabled clinical diagnostic solutions for kidney disease, improving risk assessment, clinical care, and patient stratification. Offers KidneyIntelX, a platform to assess risk of progressive decline in diabetic kidney disease; KidneyIntelX.dkd, an FDA-authorized test predicting risk in adults with type 2 diabetes and early-stage chronic kidney disease; and Well Filtered insights via blog, webinar, and podcast series.
Products and services
- KidneyIntelX.dkd: An FDA-authorized test that predicts risk of kidney function decline in adults with type 2 diabetes and early-stage chronic kidney disease
- KidneyIntelX: An AI-enabled diagnostic platform that helps clinical teams assess risk of progressive decline in kidney function in patients with diabetic kidney disease
- Well Filtered: A multi-format blog, webinar, and podcast series that delivers insights and innovations in kidney health
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Renalytix
NaphCare
HQ: United States
Website
- Description: Provider of correctional healthcare services and technology, offering a proactive care model, TechCare EHR and medical operations platform, STATCare 24/7 telehealth, Medication Assisted Treatment programs, Behavioral Health Units, and NaphCare Rx in-house pharmacy to improve inmate health, ensure compliance, and reduce costs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NaphCare company profile →
CodaMetrix
HQ: United States
Website
- Description: Provider of an AI-powered autonomous medical coding platform for healthcare revenue cycle management, translating clinical notes into billing and diagnostic codes without human intervention. Offers a cloud-based solution for patient care and revenue cycle management and CMX Amplify, a coding decision support tool embedded in EHR systems to assist coders with complex cases, improving efficiency and accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CodaMetrix company profile →
NeuronUP
HQ: Spain
Website
- Description: Provider of a platform supporting professionals involved in cognitive rehabilitation and stimulation processes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeuronUP company profile →
LifeMasters
HQ: United States
Website
- Description: Provider of disease management programs and services that create health and foster partnerships among individuals, their physicians, and payors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LifeMasters company profile →
TransChart
HQ: United States
Website
- Description: Provider of transplant support for kidney, heart, lung, liver, pancreas (Islet Cell), and small bowel.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TransChart company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Renalytix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Renalytix
2.2 - Growth funds investing in similar companies to Renalytix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Renalytix
4.2 - Public trading comparable groups for Renalytix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →